Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CVKD — Cadrenal Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to CVKD Full portfolio

Position in CVKD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$330
-$176 QoQ
Shares Held
99
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 18 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CVKD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CVKD ranks #380 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CVKD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $330 99
2026-03-31 $506 99
2025-12-31 $671 99
2025-09-30 $1,369 99
2025-06-30 $1,205 100
2025-03-31 $1,763 100
2024-03-31 $32 54
2023-12-31 $39 53
2023-09-30 $34 50
2023-06-30 $15 10
2023-03-31 $14 10